Cart is empty Although there are some cultural exceptions to the rule, medicines for children are often given in liquid form that is sweetened to make it taste good. But not every child experiences the same medicine in the same way.
New study challenges classic tenet of memory research
Connections among one set of activated neurons in rat brains grew stronger while memories were being formed, but those in another weakened, UT Southwestern Medical Center researchers have discovered. The findings, at odds with traditional thinking about how the brain operates, provide clues into the mystery of learning and memory, processes that go awry in diseases including Alzheimer’s, schizophrenia, and autism.
How do suicide risk or depression screenings compare to identify patients at risk?
Research led by The Ohio State University Wexner Medical Center and Wesleyan University found that depression screening tools outperformed suicide risk screenings under most conditions.
Global background rates study analyzes data from 197 million people for assessment of COVID-19 vaccine safety
The U.S. CDC (Centers for Disease Control and Prevention) Global COVID Vaccine Safety Project has generated background incidence rates on a range of conditions designated as AESI (Adverse Events of Special Interest) for COVID-19 vaccine safety monitoring. Conditions studied included myocarditis, pulmonary embolism, and Guillain-Barré syndrome.
Researcher investigates race and public assistance policy opinions
Despite the personal and societal costs, many people who are eligible for public assistance programs like Medicaid never enroll. The reasons behind decisions to not enroll in public assistance programs are personal and vary from person to person.
‘DOWN, NOT OUT’
…Muza coach Mathews Ndlovu still confident
By MICHAEL MIYOBA
FC Muza coach Mathews Ndlovu is confident that the Zambian envoys in the CAF Confederations Cup are not out despite a 2-1 home loss yesterday to Congo Brazzaville giants Diables Noir in the first leg second preliminary match played at Heroes Stadium in Lusaka.
This content is locked
This is exclusive material. To read full story, click on register and choose one of the premium subscriptions to view this content. Login if you are already a premium user.
Research team leads adaptive, efficient multi-arm phase 2 clinical trial for glioblastoma
An innovative phase 2 clinical trial led by Dana-Farber Cancer Institute, in collaboration with 10 major brain tumor centers around the country and designed to find new potential treatments for glioblastoma, has reported initial results in the Journal of Clinical Oncology. While none of the three therapeutics tested so far improved overall survival of patients, this adaptive platform trial, the first of its kind in neuro-oncology, has the potential to rapidly and efficiently identify therapies that benefit patients.
Rates of sexual dysfunction high in patients with schizophrenia
There is a high prevalence of sexual dysfunction among individuals with schizophrenia, according to a review published online Sept. 13 in JAMA Psychiatry.
Pigs with human brain cells and biological chips: How lab-grown hybrid lifeforms bamboozle scientific ethics
Earlier this month, scientists at the Guangzhou Institutes of Biomedicine and Health announced they had successfully grown “humanized” kidneys inside pig embryos.
Researchers discover possible new treatment for triple-negative breast cancer
Zachary Schug, Ph.D., assistant professor in the Molecular and Cellular Oncogenesis Program of the Ellen and Ronald Caplan Cancer Center at The Wistar Institute, has published a new paper in the journal Nature Cancer. Schug’s paper, titled “Acetate acts as a metabolic immunomodulator by bolstering T-cell effector function and potentiating antitumor immunity in breast cancer,” demonstrates a double-acting mechanism for fighting a particularly aggressive, difficult-to-treat form of breast cancer. Schug’s research shows how silencing a certain gene, ACSS2, may improve existing treatments for patients.